In the same direction, Qiu et al. [53] investigated thyroid hormones and outcomes in AIS patients treated with intravenous rtPA to find a new predictor for sICH and poor outcomes following thrombolysis. This evidence concerns the gene TG and androgen insensitivity syndrome.